Category: testosterone
BMS: Menopause: Misinformation and Management
The conversation around menopause is getting louder but there is still a lot of misinformation. British Menopause Society medical professionals dispel menopause misinformation, talk… Continue Reading →
World Menopause Day – 18th October
The theme for World Menopause Day 2023 is Cardiovascular Disease World Menopause Day is held every year on the 18th October. The purpose of the… Continue Reading →
In Australia, is Addyi (Flibanserin) available or what is available?
Flibanserin, the drug that gives women one extra sexually satisfying experience every two months. The United States Food and Drug Administration (FDA) approved the… Continue Reading →
Monash University – New study to see whether a skin cream can prevent heart failure in women
Find A Doctor Who Knows Menopause
Find an AMS doctor To help you find a doctor who is right for you, the AMS has assembled this search feature of AMS… Continue Reading →
AndroFeme 1 licensed for hypoactive sexual desire dysfunction in postmenopausal women
Lawley Pharmaceuticals has obtained approval for registration of AndroFeme® 1 in the Australian Register of Therapeutic Goods (ARTG) for the treatment of postmenopausal women… Continue Reading →
Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1
Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →
Tanner Pharma Group and Lawley Pharmaceuticals Initiate Global Named Patient Program for AndroFeme® 1
Friday 12th June 2020 Perth, Australia and Charlotte, USA – Lawley Pharmaceuticals and Tanner Pharma Group announced today that they have initiated a global… Continue Reading →
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.
TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019 — Lawley Pharmaceuticals today announced AndroFeme 1,… Continue Reading →
Global Consensus Position Statement on the Use of Testosterone Therapy for Women
The Global Consensus Position Statement on the Use of Testosterone Therapy for Women was simultaneously published on the 2nd September 2019 in Maturitas, Journal… Continue Reading →